Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

NVCRNVCR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in NOVOCURE LTD

GOLDMAN SACHS GROUP INC holds 963,917 shares of NVCR (NOVOCURE LTD), worth $14.6M as of 2026-Q2. The position was increased (+29.3% shares). NVCR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$14.6M

Current Shares

963,917

Total Value Change

-$13.5M

Total Shares Change

+22,427

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
963,917
+29.3%
$14.6M0.0%$15.15
35
2026-Q1
Decreased
745,435
-36.7%
$8.1M0.0%$13.30
0
2025-Q4
Increased
1.2M
+30.2%
$15.2M0.0%$13.22
36
2025-Q3
Increased
904,506
+20.5%
$11.7M0.0%$12.92
33
2025-Q2
Decreased
750,516
-24.5%
$13.4M0.0%$18.00
0
2025-Q1
Increased
993,670
+5.5%
$17.7M0.0%$18.86
30
2024-Q4
New
941,490
-
$28.1M0.0%$30.08
40

Other major holders of NVCR: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, BAILLIE GIFFORD & CO, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used